GUARNERI, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 2.873
NA - Nord America 1.664
EU - Europa 1.345
SA - Sud America 535
AF - Africa 54
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.483
Nazione #
US - Stati Uniti d'America 1.578
SG - Singapore 1.147
IT - Italia 820
CN - Cina 640
BR - Brasile 440
HK - Hong Kong 332
VN - Vietnam 249
FR - Francia 190
NL - Olanda 156
KR - Corea 120
JP - Giappone 111
BD - Bangladesh 84
IN - India 69
GB - Regno Unito 42
CA - Canada 36
AR - Argentina 35
ID - Indonesia 28
DE - Germania 25
MX - Messico 24
FI - Finlandia 21
EC - Ecuador 18
IL - Israele 18
ZA - Sudafrica 15
CO - Colombia 12
ES - Italia 12
VE - Venezuela 12
PL - Polonia 11
SA - Arabia Saudita 11
IQ - Iraq 10
MA - Marocco 10
TR - Turchia 10
UA - Ucraina 9
EG - Egitto 8
RU - Federazione Russa 8
AU - Australia 7
CL - Cile 7
CR - Costa Rica 7
AT - Austria 5
CH - Svizzera 5
LV - Lettonia 5
AL - Albania 4
DZ - Algeria 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
PY - Paraguay 4
TH - Thailandia 4
TN - Tunisia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
PK - Pakistan 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
CU - Cuba 1
DJ - Gibuti 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
YT - Mayotte 1
Totale 6.479
Città #
Singapore 683
Santa Clara 667
Hong Kong 329
Hefei 294
Lauterbourg 137
San Jose 129
Ashburn 127
Seoul 118
Beijing 100
Ho Chi Minh City 85
Tokyo 80
Milan 72
Hanoi 59
Los Angeles 58
Rome 58
São Paulo 47
New York 41
Dallas 29
Rio de Janeiro 26
Naples 25
Florence 23
Turin 23
Genoa 20
Mumbai 20
Bologna 18
Helsinki 18
Haiphong 17
Minamishinagawa 17
Bengaluru 16
Buffalo 16
Orem 16
Montreal 15
Palermo 14
Bitonto 11
Guayaquil 11
Minamimotomachi 11
Amsterdam 10
Pietragalla 10
Reggio Calabria 10
Biên Hòa 9
Brooklyn 9
Da Nang 9
Frankfurt am Main 9
London 9
Manchester 9
St Louis 9
Houston 8
Phoenix 8
Riyadh 8
Bari 7
Belo Horizonte 7
Chicago 7
Dhaka 7
Mexico City 7
Monmouth Junction 7
New Delhi 7
Toronto 7
Boardman 6
Catania 6
Denver 6
Elk Grove Village 6
Guangzhou 6
Guarulhos 6
Jakarta 6
Johannesburg 6
Las Vegas 6
San José 6
Thái Nguyên 6
Warsaw 6
Alexandria 5
Boston 5
Brasília 5
Cape Town 5
Durham 5
Fortaleza 5
Hải Dương 5
Livorno 5
Messina 5
Nuremberg 5
Padua 5
Querétaro 5
Reggio Emilia 5
Riga 5
Riverside 5
Vicenza 5
Zurich 5
Amman 4
Ankara 4
Asunción 4
Atlanta 4
Bangkok 4
Brescia 4
Can Tho 4
Cascina 4
Charlotte 4
Chennai 4
Istanbul 4
Jacksonville 4
Kingston 4
Nha Trang 4
Totale 3.816
Nome #
null 618
Neuroanatomia - Un approccio semplice e comprensibile 108
Analisi farmacologiche di nuovi sistemi nanoparticellari per il rilascio del blu di metilene con potenziali effetti nelle malattie neurodegenerative 103
Formulations used to treat ocular diseases comprising e.g. macular edema, uveitis, comprise active ingredients incorporated in nanostructured systems 100
Variazioni dell'espressione di VAPB e dei suoi prodotti di clivaggio nei pazienti con Sclerosi Laterale Amiotrofica 96
DBI (DIAZEPAM BINDING INHIBITOR) - THE PRECURSOR OF A FAMILY OF ENDOGENOUS MODULATORS OF GABA-A RECEPTOR FUNCTION - HISTORY, PERSPECTIVES, AND CLINICAL IMPLICATIONS 78
Mediatori aminoacidici della retina 77
Topical application of choline-calix[4]arene nanocarrier of silibinin reduces retinal damage in a model of Age-Related Macular Disease. 77
CRISPR/Cas9 "CLN8 null" towards a dysfunctional autophagy in CLN8-associated neuronal ceroid lipofuscinosis diseases-ePoster # 4774 76
null 76
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. II Report 76
Eye drops of Ch-Cx carrier silibinin inducing protection in a model of Age-related Macular Disease (AMD). 75
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse. 74
A bicistronic vector to study the effect of CLN8/VAPA interaction on cell physiology and eventually the pathology of CLN8-associated NLC diseases 71
CLN8 protein: a post-translation modification and subcellular distribution study for understanding CLN8 physiopathology 71
Neurosteroidogenic pathways toward retinal neurodegeneration and neuroprotection 70
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 67
The neurosteroid pregnenolone sulfate contributes to neuronal cell death 66
Expression of VAPB cleavage of products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis 64
NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES 61
Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina 60
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases 59
Low concentrations of silibinin and choline-calixarene or INU-C8-PEG carriers assembling silibinin promote antioxidant and antiapoptotic effects in neuronal and retinal epithelial cells. 58
The estrogenic retina: The potential contribution to healthy aging and age-related neurodegenerative diseases of the retina 58
Facts News & Views Organo Ufficiale della Società Italiana di NeuroPsicoFarmacologia. Numero Speciale 57
Disfunzione autofagica precoce nella malattia da accumulo lisosomiale tipo ceroidolipofuscinosi associata al gene CLN8 57
Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis 55
Studi di biodisponibilità della Silibinina strutturata in nanoparticelle per la terapia di patologie retiniche neurodegenerative 55
Relazione finale progetto Studio della degenerazione retinica in corso di lipofuscinosi ceroidea neuronale (malattia di Batten) in topi MND , FIRB-MIUR / RBAU01E3SL_001, anno 2006 54
Autophagy and mitophagy in the CLN8mnd mouse, a model of childhood neurodegenerative diseases 54
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. TELETHON Grant GGP16277 54
NEUROSTEROIDOGENESIS IN RAT RETINAS 53
Neurosteroid synthesis: an early event in retinal neurodegeneration 53
TRAIL and TRAIL neutralizing antibody in the retina and RPE/choroid of the 3xTg-AD mouse model of Alzheimer disease. 52
Effetti di nuove diketopiperazine in un modello in vivo di Degenerazione Maculare Senile 52
Iron accumulation and retinal pathology: neuroprotection by diketopiperazines 52
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with Vesicle-Associated Membrane Protein-associated Protein A (VAPA), and genotype-phenotype correlations 52
null 51
Different early ER-stress responses in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 50
Neglected CLN8 protein function in the neuronal ceroid lipofuscinoses (NCLs). 50
A potential interactome map of CLN8 protein involved in the late-infantile form of neuronal ceroid lipofuscinosis. 50
METHYL MERCURY ENHANCES TRITIUM LABELED DIAZEPAM BINDING IN DIFFERENT AREAS OF THE RAT BRAIN 49
Orphanet - Il portale delle malattie rare e dei farmaci orfani: The CLN8 variant late-infantile neuronal ceroid lipofuscinosis (CLN8-vLINCL): functional aspects of the CLN8 protein and characterization of the degenerative mechanisms . 49
Effect of uridine of GABA receptors. 48
HIPPOCRATES PON02_00355 Regione Sicilia - Sviluppo di Micro e Nano-Tecnologie e Sistemi Avanzati per la Salute dell'uomo. 47
CNR Environment and Health Inter-departmental Project: present knowledge and prospects for future research. 46
Retinal oxidation and apoptosis in the motor neuron degeneration mouse, a model of neuronal ceroid lipofuscinosis 46
Structure specificity of ER stress in the Cln8-mnd mouse model of the late-infantile neuronal ceroid. 45
null 44
The role of autophagy in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 44
Does neurosteroidogenesis contribute to neuronal excitotoxicity? 43
17b-estradiol synthesis in the adult male rat retina. 43
Human neuroblastoma SH-SY5Y cell line: Neurosteroid-producing cell line relying on cytoskeletal organization 43
The protective role of estrogen-receptor-beta in retinal excitotoxicity. 41
Tackling mechanisms of CLN8 mutations in neuronal ceroid lipofuscinosis (NCLs). 41
Sustained release of silibinin to the posterior segment of the eye by mucoadhesive NLC 41
CAMP/PKA-linked phosphorylation and cytoskeletal organization are required for cholesterol transport and neurosteroid synthesis in neuroblastoma SH-SY5Y cells 40
An early impact of ER stress, inflammation and oxidative stress in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis 40
Identification of an antigen related to the sea urchin RNA-binding protein LP54 in mammalian central nervous system. 39
Riunione Annuale CLNet 39
Sistemi modello di patologie retiniche e neurodegenerative e strategie per la comprensione, la diagnosi e la terapia. 39
CLN8 interactors: a possible function of the CLN8 protein in the lipid metabolism and autophagy 38
Execution pathways of pregnenolone sulfate-induced retinal apoptosis 37
TARGETING TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND AMELIORATES RETINAL PATHOLOGY IN A TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE 36
Tumor necrosis factor-related apoptosis inducing ligand/glucocorticoid-induced TNF receptor ligand redundancy in neurodegenerative processes 36
Retinopatia diabetica sperimentale: ruolo dei gangliosidi. 35
Peripheral-type benzodiazepine receptor role in the regulation of steroid and neurosteroid biosynthesis 35
Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis 35
La patogenesi delle varianti CLN8 nelle ceroidolipofuscinosi. 34
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration 33
GAMMA-AMINOBUTYRIC-ACID TYPE-A BENZODIAZEPINE RECEPTORS REGULATE RAT RETINA NEUROSTEROIDOGENESIS 33
CLN8 and VAPA, a possible protein-protein interaction at the ER for the regulation of lipid metabolism 33
Orphanet - Il portale delle malattie rare e dei farmaci orfani: Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers . 33
Modelli retinici per le nanotecnologie e il biomonitoraggio ambientale 32
The protective role of Estrogen-Receptor-Beta in retinal excitotoxicity. 32
High vulnerability of estrogen-producing retinal cells to excitotoxic insult: downregulation of P450 aromatase activity 32
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse 32
Ruolo degli estrogeni nella neuroprotezione della retina 31
Modulation of neurosteroidogenesis by NMDA receptors is an early event involved in acute excitotoxicity 31
PATHOGENIC MECHANISMS IN THE CLN8 FORM OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS. NEW INSIGHTS INTO THE VISUAL LOSS FROM THE CLN8mnd MOUSE MODEL 30
Prodotto l anticorpo anti-CLN8, proteina implicata in una patologia neurodegenerativa rara del bambino. 30
Structure specificity of ER stress in the CLN8-MND mouse model of the late-infantile neuronal ceroid lipofuscinosis. 30
DeadEndTM Colorimetric apoptosis detection system for the analysis of retinal apoptosis 30
IN VIVO EFFECTS OF 17BETA-ESTRADIOL AND DHT ON THE RAT RETINA: A PROTEOMIC APPROACH 30
Functional analysis of L-3H Iysine binding to the rat retina. 29
Uridina e complesso recettoriale GABA Benzodiazepine ionoforo. 29
Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity 29
CLN8 and VAP-A, a possible protein-protein interaction at the ER for the regulation of lipid metabolism and with implication in neurodegenerative diseases. 29
TRITIATED L LYSINE BINDING TO RAT RETINAL MEMBRANE II. EFFECT OF KAINIC ACID D L-ALPHA AMINOADIPIC ACID IODOACETIC ACID AND MODIFICATION BY DARK-EXPOSURE 28
Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system 28
A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-speci.c caspase-2 activation in the retinal cell death 28
ENDOPLASMIC RETICULUM STRESS AND THE UNFOLDED PROTEIN RESPONSE IN THE Cln8mnd MOUSE MODEL OF NEURONAL CEROID LIPOFUSCINOSES (NCLS) 28
GABA and benzodiazepine receptors in the rat retina: loss of their functional interaction with age. 28
INVOLVEMENT OF p38 AND JNK mapks PATHWAYS IN SUBSTANCE P-INDUCED PRODUCTION OF TNF - BY PERITONEAL MAST CELLS 28
Neurosteroidogenic pathways toward retina neurodegeneration or neuroprotection 28
Retinal steroidogenic machinery: expression and activity of P450scc, P450c17, 3bHSD, P450aromatase 28
ER stress and inflammation, two interactive responses in neurodegenerative processes. 27
Changes in the sensitivity of benzodiazepine and GABA receptors induced by light and dark adaptation 27
INTERACTION OF URIDINE WITH GAMMA AMINO BUTYRIC-ACID BINDING SITES IN CEREBELLAR MEMBRANES OF THE RAT 27
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. 27
Totale 5.313
Categoria #
all - tutte 19.742
article - articoli 6.664
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.118
Totale 27.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202431 0 0 0 0 0 0 0 0 17 3 5 6
2024/20252.485 14 9 162 120 635 62 29 71 121 151 598 513
2025/20263.775 209 400 342 575 637 128 492 230 250 189 155 168
2026/2027192 192 0 0 0 0 0 0 0 0 0 0 0
Totale 6.483